To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.
DRAVP ID DRAVPa2055
Peptide Name Sequence 13 from Patent US10745448B2
Sequence MQRKPTIRRKNLRLRRK
Sequence Length 17
Source Synthetic peptide
Target Organism VSV
Patent Type Granted Patent
Publication Date 2020-08-18
Patent No US10745448B2
Family Info JP6994714B2
Patent Title Antiviral peptide and use therefor
Comment
Abstract An antiviral peptide provided by the present invention includes:(1) the signal sequence of a glycoprotein encoded for by the G gene of the vesicular stomatitis virus (VSV), or the signal sequence of hemagglutinin encoded for by the HA gene of the influenza A or influenza B virus, or a modified amino acid sequence formed by conservative substitution of 1, 2 or 3 amino acid residues in any of these signal sequences; and (14) an amino acid sequence that functions as a cell penetrating peptide (CPP).
To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.